Skip to content
SUNY Upstate Medical University logo

Upstate Biotech Ventures

Visit program ↗Check the fit ↓
About the program · 2 linked sources

A $6 million seed fund managed by Excell Partners that invests in high-potential startups and small businesses affiliated with SUNY Upstate Medical University. It is the first venture capital fund established on a SUNY campus and is closely linked to the CNY Biotech Accelerator.

How we know this: the figures on this page come from the linked sources (last verified 2026-06-22); what those sources do not state is left unknown.

Key numbers

Funding range

$1,000,000

Venture Equity

Equity

Equity taken

Application

Ongoing

Campus Wide

Last activity

2024-07-16

High confidence

Keep this on your radar Deadline reminders ↓

Reminders

Upstate Biotech Ventures

Get an email before a director-verified deadline for this program, this school, or this state. The program never sees your address.

Student experiences · Read or add a note

Student notes

Upstate Biotech Ventures

No posts yet.

    Post what happened. A .edu account is required. Your name and email stay off this page.

    Rating

    0/280

    Application and Timing

    The fund was announced July 16, 2024, with active deployment expected across 2024–2028. Application mechanics and review cycle are managed through Excell Partners.

    Participants

    Biotech and health-related startups with SUNY Upstate affiliation, especially those in or linked to CNYBAC. Preference is given to businesses led by founders from traditionally underrepresented groups.

    Funding and Equity

    The fund was capitalized with $6 million: $3 million from Empire State Development's Community and Regional Partner Fund (SSBCI) and $3 million from Upstate Medical University through the SUNY Research Foundation. Investments range from $100,000 to $1 million across approximately 20 companies. Terms are managed by Excell Partners and imply standard venture-equity or equity-like structures. Exact security types for each investment are not detailed in the retained sources.

    Recent Activity

    The 2026 New York State CNYBAC renovation announcement confirms Upstate Biotech Ventures as an active capital source for accelerator clients. No subsequent deployment data was captured.

    Known startups and winners

    Competition winners and notable student ventures from our research.

    See every startup
    Historical winners (research notes)

    The early portfolio is not yet fully public. Expected to include CNYBAC and Upstate-affiliated ventures as they raise seed rounds.

    Research gaps & things to verify

    Verification Gaps

    • Current deployment totals and portfolio companies.
    • Exact security terms and investment track record.
    • Application process and timeline through Excell Partners.
    Program details

    Upstate Biotech Ventures

    Additional research notesShow